Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002442316 | SCV002746390 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | The p.G100S variant (also known as c.298G>A), located in coding exon 3 of the CDC73 gene, results from a G to A substitution at nucleotide position 298. The glycine at codon 100 is replaced by serine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV003464561 | SCV004215587 | uncertain significance | Hyperparathyroidism 1 | 2023-05-31 | criteria provided, single submitter | clinical testing |